Home > Boards > US Listed > Biotechs > AEterna Zentaris Inc. (AEZS)

Wrong. Wrong and wrong. You couldn't

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Investwisely123 Member Profile
 
Followed By 1
Posts 39
Boards Moderated 0
Alias Born 11/16/18
160x600 placeholder
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/10/2019 4:01:58 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/6/2019 2:32:15 PM
Aeterna Zentaris Provides Corporate Update GlobeNewswire Inc. - 6/6/2019 2:06:40 PM
Amended Securities Registration (section 12(b)) (8-a12b/a) Edgar (US Regulatory) - 5/9/2019 4:32:19 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/9/2019 4:10:06 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/9/2019 6:08:45 AM
Aeterna Zentaris Announces Results of Annual and Special Shareholders’ Meeting GlobeNewswire Inc. - 5/8/2019 6:04:22 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/7/2019 5:23:29 PM
Aeterna Zentaris Reports First Quarter 2019 Financial and Operating Results GlobeNewswire Inc. - 5/7/2019 5:12:12 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/7/2019 4:40:07 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/1/2019 6:24:31 AM
Annual and Transition Report (foreign Private Issuer) (20-f) Edgar (US Regulatory) - 4/1/2019 6:03:58 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/27/2019 2:04:26 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/26/2019 5:28:03 PM
Aeterna Zentaris Reports Fourth Quarter and Full-Year 2018 Financial and Operating Results GlobeNewswire Inc. - 3/26/2019 5:22:03 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/22/2019 4:43:08 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/19/2019 8:02:18 AM
Aeterna Zentaris to Announce Fourth Quarter and Year End 2018 Financial and Operating Results on March 26, 2019 GlobeNewswire Inc. - 3/19/2019 8:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 3/18/2019 6:09:40 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/12/2019 4:51:23 PM
Aeterna Zentaris Announces Strategic Review and Engagement of Financial Advisor GlobeNewswire Inc. - 3/12/2019 4:32:37 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/22/2019 1:18:07 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/11/2019 3:28:01 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/11/2019 1:42:02 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 1/16/2019 9:09:31 AM
Investwisely123   Monday, 01/07/19 07:47:13 AM
Re: ernie44 post# 16166
Post # of 16211 
Wrong. Wrong and wrong. You couldn't be more wrong. Aezs stock is still a huge bargain at the current price. We could see $6-$7 on European approval of Macrilen as early as this week. Then i think Aezs immediately after European approval will either enter into a big licensing deal for Macrilen and the share price will go to $12-$15 or alternatively AEZS will get bought out by Novo Nordisk or other big pharma for $18-20 per share. These are just my opinions. Do your own research and due diligence.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist